A network meta-analysis on the efficacy of targeted agents in combination with chemotherapy for treatment of advanced/metastatic triple-negative breast cancer-Reference-Cited by-同舟云学术

A network meta-analysis on the efficacy of targeted agents in combination with chemotherapy for treatment of advanced/metastatic triple-negative breast cancer

Published:2017-07-08 Issue:35 Volume:8 Page:59539-59551
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ge Long¹²³,Tang Yan⁴,Zhang Qiu-Ning⁵,Tian Jin-Hui²³,Wang Xiao-Hu⁴⁵,Pieper Dawid⁶,Pan Bei⁷,Li Lun⁸,Ling Juan²³,Bing Zhi-Tong⁹,Yang Ke-Hu²³

Affiliation:

1. First Clinical Medical College of Lanzhou University, Lanzhou 730000, P.R. China

2. Evidence-Based Medicine Center of Lanzhou University, Lanzhou 730000, P.R. China

3. Key Laboratory of Evidence-Based Medicine and Knowledge Translation of Gansu Province, Lanzhou 730000, P.R. China

4. Second People's Hospital of Lanzhou City, Lanzhou 730046, P.R. China

5. Gansu Provincial Academic Institute for Medical Research, Gansu Provincial Cancer Hospital, Lanzhou 730050, P.R. China

6. Institute for Research in Operative Medicine, Faculty of Health, School of Medicine, Witten/Herdecke University, 51109, Cologne, Germany

7. School of Public Health of Lanzhou University, Lanzhou 730000, P.R. China

8. Department of Breast-Thyroid Surgery, The Second Xiangya Hospital of Central South University, Changsha 410000, P.R. China

9. Institute of Modern Physics of Chinese Academy of Sciences, Lanzhou 730000, P.R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis;Diabetes, Metabolic Syndrome and Obesity;2024-06

2. A meta-analysis of application of PD-1/PD-L1 inhibitor-based immunotherapy in unresectable locally advanced triple-negative breast cancer;Immunotherapy;2023-09

3. The effect and safety of CDK4/6 inhibitors combined endocrine therapy on HR+, HER2-breast cancer: a meta-analysis of randomized controlled trials;Endokrynologia Polska;2023-02-27

4. Aspectos clínicos y terapéuticos del carcinoma de mama metastásico triple negativo;Anales Médicos de la Asociación Médica del Centro Médico ABC;2022

5. A meta-analysis of the effect and safety of platinum-based neoadjuvant chemotherapy in treatment of resectable triple-negative breast cancer;Anti-Cancer Drugs;2021-08-06